Talbutal
| Talbutal | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 224.26 g/mol [1] |
| Appearance | CRYSTALS FROM WATER OR DIL ALCOHOL [1] |
| Odor | MAY HAVE SLIGHT ODOR OF CARAMEL [1] |
| Taste | SLIGHTLY BITTER TASTE [1] |
| Melting point | 109 °C [1] |
| Solubility | 1810 mg/L at 25 °C [1] |
| Predicted LogP | 1.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H16N2O3 |
| IUPAC name | 5-butan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione |
| SMILES | CCC(C)C1(C(=O)NC(=O)NC1=O)CC=C |
| InChI | InChI=1S/C11H16N2O3/c1-4-6-11(7(3)5-2)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16) |
| InChIKey | BJVVMKUXKQHWJK-UHFFFAOYSA-N |
| CAS number | 115-44-6 |
| UNII | 4YIR8202AX |
| PubChem CID | 8275 |
Talbutal (also known as Lotusate, Profundol, 5-Allyl-5-sec-butylbarbituric acid, Talbutale, Talbutalum, sec-Butyl allyl barbituric acid, Win 5095, Barbituric acid, 5-allyl-5-sec-butyl-, 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylpropyl)-5-(2-propenyl)- or 5-(butan-2-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione) is a substance of the barbiturate class.
Chemistry
Stereochemistry []
Talbutal is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Talbutal matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- hypnotics and sedatives (N05C)
- barbiturates, plain (N05CA)
- talbutal (N05CA07)
Mechanism of action []
Talbutal binds to GABA<sub>A</sub> receptors at a distinct binding site associated with a Cl<sup>-</sup> ionopore of the receptor. Upon binding, talbutal increases the duration of time for which the Cl<sup>-</sup> ionopore is open, leading to prolonged inhibitory effect of GABA at the postsynaptic thalamic neuron. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| GABRA1 | shared target | 32 |
|---|---|---|
| GABRA2 | shared target | 32 |
| GABRA3 | shared target | 32 |
| GABRA4 | shared target | 32 |
| GABRA5 | shared target | 32 |
| GABRA6 | shared target | 32 |
| GABRB1 | shared target | 32 |
| GABRB2 | shared target | 32 |
| GABRB3 | shared target | 32 |
| GABRD | shared target | 32 |
| GABRE | shared target | 32 |
| GABRG1 | shared target | 32 |
| GABRG2 | shared target | 32 |
| GABRG3 | shared target | 32 |
| GABRP | shared target | 32 |
| GABRQ | shared target | 32 |
Legal status []
- Canada: Talbutal is a Schedule IV.
- United States: Talbutal is a Schedule III under the "Controlled Substances Act".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 8275, Talbutal. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/8275
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Talbutal. UNII: 4YIR8202AX. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4YIR8202AX
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:02:02 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 18:01:58 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 18:01:58 |
| gsrs | ok | 2026-11-20 18:01:59 |
| hmdb | missing (no HMDB id) | 2026-11-20 18:01:58 |
| kegg | ok | 2026-11-20 18:02:00 |
| pubchem | ok | 2026-11-20 18:01:57 |
| missing (no r/tripreports posts mention it) | 2026-11-20 18:01:58 | |
| sider | missing (not in SIDER) | 2026-11-20 18:01:58 |
| structure | ok | 2026-11-20 18:01:58 |
| wikipedia | ok | 2026-11-20 18:01:59 |